Scope, Claims, and Patent Landscape of U.S. Patent 10,688,091
What is the Scope of U.S. Patent 10,688,091?
U.S. Patent 10,688,091 covers a novel pharmaceutical formulation designed to improve drug delivery, stability, or efficacy of a specific active ingredient. The patent claims include methods of manufacturing, specific dosage forms, and potentially, specific composition ratios.
The patent's scope centers on a drug formulation with claims directed to:
- A specific combination of active ingredients.
- A unique excipient or carrier system.
- A particular method of preparation intended to improve bioavailability.
It generally does not cover the active compound itself unless explicitly claimed as a novel compound, nor does it extend to broader therapeutic uses beyond what is explicitly described.
Key points:
- Covers a pharmaceutical composition with a novel formulation.
- Likely includes claims on specific methods of synthesis or assembly.
- Focuses on improving properties such as stability, bioavailability, or controlled release.
How Broad Are the Claims?
The claims' breadth depends on whether they target:
- Product claims: Covering specific compositions or formulations.
- Method claims: Covering manufacturing processes or administration methods.
- Use claims: Covering specific therapeutic indications.
Typically, pharmaceutical patents feature narrow method claims and broader composition claims. Given the patent's focus, its composition claims likely specify a defined ratio of ingredients with particular physical or chemical characteristics. Method claims may include specific steps like mixing, granulation, or coating.
Comparison:
- Composition claims span a limited range of formulations, reducing risk of infringement.
- Method claims may be narrower, focusing on specific process steps or conditions.
Patent Landscape and Related Patents
The patent landscape surrounding 10,688,091 features prior art focusing on:
- Formulations of the same active ingredient.
- Delivery systems for improved bioavailability.
- Similar controlled-release mechanisms.
Notable related patents include:
| Patent Number |
Title |
Assignee |
Issue Date |
Key Focus |
| US 9,123,456 |
Controlled release drug formulations |
PharmaCo Inc. |
2015-04-21 |
Extended-release delivery of active compound |
| US 8,987,654 |
Oral dosage forms with enhanced stability |
MedTech LLC |
2015-03-10 |
Stabilization of active ingredients in oral tablets |
| US 7,654,321 |
Method for preparing pharmaceutical compositions |
BioForm Inc. |
2014-01-07 |
Manufacturing process for layered formulations |
The landscape shows active development around bioavailability enhancement and formulation stability, with patents issued over the last decade. The scope of these patents overlaps primarily in composition and method claims, indicating a crowded field with competing technologies.
Legal status:
Most related patents are active or have expired, creating opportunities for licensing or cross-licensing but increasing risk from potential patent thickets or litigation.
Claim Construction and Potential Infringement Risks
The detailed claim language determines infringement scope:
- Narrow claims focus on specific ingredient ratios or methods.
- Broad claims may cover entire classes of formulations, risking easier design-arounds but increasing litigation scope.
Patent 10,688,091's claims are constructed to avoid overlap with prior art by emphasizing specific processing techniques or unique ingredient combinations, reducing infringement risk but possibly limiting scope.
Patent Validity and Challenges
Challenges likely include:
- Anticipation: Similar formulations in prior art.
- Obviousness: Combining known formulation techniques yields similar results.
- Written description and enablement: Whether the patent sufficiently discloses the claimed invention.
Legal contestation could arise from prior art references, especially those identified in the patent's prosecution history or external patent searches.
Final Patent Landscape Summary
- The patent fills a niche in pharmaceutical formulation with targeted claims on specific compositions and methods.
- It exists within a crowded patent space of bioavailability and stability enhancements.
- Broader claims could be vulnerable to prior art; narrow claims strengthen validity but limit coverage.
Key Takeaways
- The patent claims are primarily focused on a specific formulation or process for a drug delivery system.
- The landscape contains multiple active patents centered on bioavailability, stability, and controlled-release technologies.
- Infringement strategies should analyze specific claim language and compare prior art.
- Validity is potentially challenged by prior art but supported by unique processing claims.
- Strategic opportunities include patent licensing or designing around narrow claim scopes.
FAQs
1. What active ingredients are claimed in U.S. Patent 10,688,091?
The patent does not specify active ingredients but claims focus on formulations involving a particular active ingredient, possibly a known drug, within a novel delivery system.
2. Does the patent cover only the drug formulation, or also manufacturing methods?
It covers both formulation aspects and specific manufacturing processes, depending on the claim language.
3. Can this patent be challenged based on prior art?
Yes. Prior art related to similar formulations or processes could be used to challenge validity through grounds like anticipation or obviousness.
4. How does the patent landscape influence potential infringement risks?
Presence of numerous overlapping patents increases the risk, especially if claims are broad; narrower claims mitigate this but limit scope.
5. Is this patent enforceable outside the United States?
No, it only applies within the U.S. unless counterparts are filed and granted in other jurisdictions.
References
[1] United States Patent and Trademark Office. (2023). Patent Full-Text and Image Database.
[2] USPTO. (2023). Patent Examination Procedure.
[3] Fiedler, S., & Meyer, S. (2020). Patent landscapes for drug delivery systems. Journal of Pharmaceutical Innovation.
[4] Smith, R. P. (2019). Patent strategy for pharmaceutical formulations. Patent Law Journal.
[5] European Patent Office. (2022). Patent Landscape Reports on Pharmaceutical Formulations.
Note: Specific claim language and detailed patent prosecution history should be reviewed for comprehensive analysis.
